Veraxa Biotech (VRXA) director Christoph Ziegler reports 7,932 Ordinary Shares
Rhea-AI Filing Summary
Veraxa Biotech Holding AG director reports initial shareholdings. Christoph Samuel Ziegler filed a Form 3 showing ownership of 7,932 Ordinary Shares of Veraxa Biotech Holding AG. The filing is an initial statement of beneficial ownership and does not report any specific recent purchase or sale transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Ziegler Christoph Samuel
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 7,932 shares (Direct)
Key Figures
Director shareholding: 7,932 Ordinary Shares
Reported buy transactions: 0 shares
Reported sell transactions: 0 shares
3 metrics
Director shareholding
7,932 Ordinary Shares
Total shares beneficially owned following reported holdings
Reported buy transactions
0 shares
Form 3 transaction summary buyShares
Reported sell transactions
0 shares
Form 3 transaction summary sellShares
Key Terms
Form 3, Ordinary Shares, beneficial ownership, direct or indirect ownership code
4 terms
Form 3 regulatory
"INSIDER FILING DATA (Form 3): {"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership regulatory
""holdingEntries": 1, "netBuySellDirection": "neutral" (initial beneficial ownership)"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
direct or indirect ownership code regulatory
""direct_or_indirect": "D", "ownership_code": "D""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Veraxa Biotech (VRXA) disclose in this Form 3 filing?
The Form 3 shows director Christoph Samuel Ziegler’s initial beneficial ownership of Veraxa Biotech. He reports holding 7,932 Ordinary Shares, giving investors a baseline view of his direct equity stake at the time of becoming a reporting insider.
Does the Veraxa Biotech (VRXA) Form 3 show recent insider buying or selling?
The Form 3 functions as an initial ownership statement and does not list any specific buy or sell transactions. It simply records Christoph Samuel Ziegler’s existing holding of 7,932 Ordinary Shares when he became an insider required to report.
What type of security does the Veraxa Biotech (VRXA) insider hold?
The insider, Christoph Samuel Ziegler, holds Ordinary Shares of Veraxa Biotech Holding AG. The Form 3 discloses a direct beneficial ownership position of 7,932 Ordinary Shares, clarifying that his stake is in the company’s common equity rather than derivatives.
Is the ownership in Veraxa Biotech (VRXA) held directly or indirectly?
The Form 3 labels Christoph Samuel Ziegler’s 7,932-share position as direct ownership, using the ownership code “D.” Direct ownership means the shares are held in his own name rather than through a trust, partnership, or other intermediary entity.